Related content

Effects of switching from NPH insulin to insulin glargine in patients with type 2 diabetes: the retrospective, observational LAUREL study in Italy

By Bellia Alfonso   Babini Anna   Marchetto Paolo   Arsenio Leone   Lauro Davide   Lauro Renato  

Acta Diabetologica, Vol. 51, Iss. 2, 2014-04 ,pp. : 269-275

Springer Publishing Company

Access to resources Recommend Favorite

Comparison between the effects of the rapid recombinant insulin analog aspart and those of human regular insulin on platelet cyclic nucleotides and aggregation

By Russo I.   Massucco P.   Mattiello L.   Cavalot F.   Anfossi G.   Trovati M.  

Thrombosis Research, Vol. 107, Iss. 1, 2002-07 ,pp. : 31-37

Elsevier

Access to resources Recommend Favorite

Spotlight on Insulin Aspart in Type 1 and 2 Diabetes Mellitus

By Chapman T.M.   Noble S.   Goa K.L.  

Treatments in Endocrinology, Vol. 2, Iss. 1, 2003-01 ,pp. : 71-76

Adis International

Access to resources Recommend Favorite

The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy

By Sahin S.  

Acta Diabetologica, Vol. 47, Iss. 4, 2010-12 ,pp. : 325-330

Springer Publishing Company

Access to resources Recommend Favorite

Premixed insulin aspart 30 (BIAsp 30) versus premixed human insulin 30 (BHI 30) in gestational diabetes mellitus: a randomized open-label controlled study

By Balaji Vijayam   Balaji Madhuri S.   Alexander Cynthia   Srinivasan Ashalata   Suganthi Sheela R.   Thiyagarajah Arthi   Seshiah Veerasamy  

Gynecological Endocrinology, Vol. 28, Iss. 7, 2012-07 ,pp. : 529-532

Informa Healthcare

Access to resources Recommend Favorite